adjuvant radiotherapies การใช้

• However, none of the studies showed that adjuvant radiotherapy had a statistically significant survival benefit.
• Multiple studies have shown that adjuvant radiotherapy improves local recurrence rates in high-risk melanoma patients.
• However, if complete resection cannot be achieved, adjuvant radiotherapy should be added to improve local control.
• More detailed surgical technique and the support for additional adjuvant radiotherapy depends on whether the tumor is malignant or benign.
• The addition of adjuvant radiotherapy ( irradiation ) improves local control in patients with close or positive margins during the surgery.
• Adjuvant radiotherapy follows surgical resection; this combined approach has been shown to prolong median survival up to 12 months, depending on the factors noted above.
• Adjuvant chemotherapy and adjuvant radiotherapy are directed at killing any micrometastases, thus preventing relapse ( regrowth of the cancer ) and the ( likely ) death of the patient.
• In early stage one small cell lung carcinoma, adjuvant chemotherapy with gemzar, cisplatin, paclitaxel, docetaxel, and other chemotherapeutic agents, and adjuvant radiotherapy is administered to either the lung, to prevent a local recurrence, or the brain to prevent metastases.
• Adjuvant radiotherapy has been shown to be effective in reducing the rates of recurrence and in increasing the survival of patients with MCC . Patients who present with no distant metastases and a negative sentinel lymph node biopsy have a very good prognosis when treated with both surgery and radiotherapy ( approximately 90 % survival rate at five years ).